ReviewGenes2026
Progress in the Application of Machine Learning in the Field of Single-Cell and Spatial Transcriptomics.
Review in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The rapid evolution of transcriptome sequencing technologies has driven significant breakthroughs across the life sciences. The advent of single-cell RNA-sequencing (scRNA-seq) has enabled gene expression profiling at single-cell resolution, whereas spatial transcriptomics further contextualizes these transcriptional profiles within preserved tissue morphology. Concurrently, advancements in artificial intelligence have introduced unprecedented opportunities in bioinformatics. As a core component of artificial intelligence, machine learning (ML) substantially outperforms traditional computational methods in deciphering complex, high-dimensional biological data. This review systematically summarizes the significant advantages of integrating ML algorithms into transcriptomic workflows. By leveraging these advanced computational tools, researchers can efficiently extract comprehensive biological insights, elucidate intricate Gene Regulatory Networks, and generate intuitive visualizations. Ultimately, ML-driven transcriptomics provides a robust technical foundation for disease diagnosis, drug discovery, and precision medicine. These advancements underscore the pivotal role of ML in transforming transcriptomic data analysis into an intelligent, highly precise, and multidimensional discipline, thereby accelerating future biological discoveries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.